Lee Ainslie Atri Cure, Inc. Transaction History

Maverick Capital LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2021 Nov 15, 2021	SELL	$69.28 - $84.46 $295,617 - $360,390	-4,267 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$64.13 - $80.18 $111,842 - $139,833	-1,744 Reduced 29.01%	4,267 $339,000
Q1 2021 May 17, 2021	BUY	$53.79 - $66.98 $323,331 - $402,616	6,011 New	6,011 $394,000

221

51.8M

33.5K

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.63B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

Get notified when there are updates to the investment portfolio of Maverick Capital LTD, based on Form 13F filings with the SEC.

Stay updated on Maverick Capital LTD and Lee Ainslie with notifications on news.